Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Institute Of Medicinal Biotechnology, Chinese Academy Of Medical Sciences

Clinical trials sponsored by Institute Of Medicinal Biotechnology, Chinese Academy Of Medical Sciences, explained in plain language.

Not yet recruiting 1

New drug aims to protect kidneys in diabetes patients

Disease control Not yet recruiting

This study tests whether the investigational drug HTD1801 can slow the worsening of kidney disease in adults who have both type 2 diabetes and chronic kidney disease. About 75 participants will receive either HTD1801 or a placebo twice daily for 12 weeks. The main goal is to see …

Phase: PHASE2 • Sponsor: Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences • Aim: Disease control

Last updated May 14, 2026 12:03 UTC